LD-2 disclosure · 2nd Quarter - Report
PAR PHARMACEUTICAL
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Developer, manufacturer, and marketer of generic and branded specialty pharmaceuticals
- Location
- New Jersey · United States of America
Registrant
- Description
- law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
FDA issues
LobbyistsJENNIFER FITZGERALD WALSH
TargetedSENATE · HOUSE OF REPRESENTATIVES